Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2011-12-13Clinical Trial Update: Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma Cases
This clinical trial update notes prospective data collection of newly diagnosed Hodgkin lymphoma and Non-Hodgkin lymphoma cases at King Fais…
-
CLINICAL_TRIALS trial_result · 2011-12-07Clinical Trial Update: Tipifarnib in Treating Patients With Relapsed or Refractory Lymphoma [Phase 2]
Phase 2 clinical trial evaluating tipifarnib in relapsed or refractory lymphoma has completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma [Phase 2]
This clinical trial update reports the results of a pivotal open-label Phase 2 study of Brentuximab Vedotin in Hodgkin lymphoma, sponsored b…
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated the safety and preliminary efficacy of SGN-30 (brentuximab vedotin) in patients with CD30-positive …
-
CLINICAL_TRIALS trial_result · 2011-09-28Clinical Trial Update: Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients [Phase 1]
This Phase 1 study evaluated the safety and tolerability of an oral capsule form of PCI-24781 in adults with advanced cancers, and the trial…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-08-26Clinical Trial Update: Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial update reports completion of a study evaluating radiation therapy with cyclophosphamide followed by peripheral stem cell …
-
FDA approval · 2011-08-19FDA Approved: ADCETRIS — Original Application (SEAGEN INC.)
FDA approved ADCETRIS (brentuximab vedotin) in its original application for CD30-expressing classical Hodgkin lymphoma and systemic anaplast…
-
FDA approval · 2011-08-19FDA Approved: ADCETRIS — Supplemental Application (SEAGEN INC.)
The FDA approved a supplemental application for ADCETRIS (brentuximab vedotin) submitted by Seagen Inc.
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: Trial of AVN-944 in Patients With Advanced Hematologic Malignancies [Phase 1]
A Phase 1 trial evaluating AVN-944 in patients with advanced hematologic malignancies has completed, spanning acute and chronic leukemia, mu…
-
CLINICAL_TRIALS trial_result · 2011-08-04Clinical Trial Update: HD11 for Intermediate Stages [Phase 3]
A Phase 3 clinical trial named HD11 for intermediate-stage Hodgkin lymphoma has completed, sponsored by the University of Cologne. The snipp…
-
CLINICAL_TRIALS trial_result · 2011-07-29Clinical Trial Update: Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma [Phase 2]
Phase 2 trial evaluating BACOPP-21 for feasibility and efficacy in patients over 60 with intermediate or advanced Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2011-07-29Clinical Trial Update: HD10 for Early Stages [Phase 3]
Sponsored by the University of Cologne, the Phase 3 trial HD10 for early-stage Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS research · 2011-07-20Clinical Trial Update: Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's Disease [Phase 2]
Phase 2 clinical trial comparing R-mabHD to ABVD in Hodgkin lymphoma is currently ongoing with the study status listed as UNKNOWN. No result…
-
CLINICAL_TRIALS trial_result · 2011-07-20Clinical Trial Update: Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma [Phase 3]
This entry reports an ongoing Phase 3 clinical trial evaluating the monoclonal antibody R-mabHDI for Hodgkin lymphoma with a status listed a…
-
CLINICAL_TRIALS trial_result · 2011-05-30Clinical Trial Update: 17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma [Phase 2]
The National Cancer Institute completed a Phase 2 trial of tanespimycin (17-AAG) in relapsed or refractory Anaplastic Large Cell Lymphoma, M…
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy [Phase 3]
A Phase 3 study evaluating weekly epoetin alfa (PROCRIT) versus placebo for anemia and quality of life in children receiving chemotherapy fo…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High Grade [NA]
A completed trial evaluating whether tomoscintigraphy with MIBI can predict chemotherapy response in patients with Hodgkin lymphoma and high…
-
CLINICAL_TRIALS research · 2011-02-21Clinical Trial Update: Etoposide, Methylprednisolone, High-dose Cytarabine and Oxaliplatin (ESHAOx) for Refractory or Relapsed Hodgkin's Lymphoma (HL) [Phase 2]
A Phase 2 clinical trial is testing ESHAOx (etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin) for refractory or relapsed…
-
CLINICAL_TRIALS trial_result · 2011-01-12Clinical Trial Update: Pentostatin and Alemtuzumab as a Preparative Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating a pentostatin-alemtuzumab preparative regimen for allogeneic peripheral blood stem cell transplantation; the study …
-
CLINICAL_TRIALS trial_result · 2010-12-09Clinical Trial Update: Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 clinical trial update describes the combination of vorinostat and lenalidomide in patients with relapsed or refractory Hodgkin lym…
-
CLINICAL_TRIALS research · 2010-11-11Clinical Trial Update: Hybrid SPECT/CTCA for the Assessment of the Presence and Hemodynamic Significance of CAD in Asymptomatic Patients. [NA]
This clinical trial update assesses the use of Hybrid SPECT/CTCA imaging to determine the presence and hemodynamic significance of coronary …
-
CLINICAL_TRIALS research · 2010-10-29Clinical Trial Update: Host Dendritic Cells in Allograft Patients [Phase 1]
Phase 1 clinical trial update from Icahn School of Medicine at Mount Sinai evaluating host dendritic cells in allograft patients for relapse…
-
CLINICAL_TRIALS trial_result · 2010-10-11Clinical Trial Update: Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors [Phase 1, Phase 2]
This clinical trial update summarizes a Phase 1/2 study of tandem peripheral blood stem cell rescue for high-risk solid tumors. Eligible con…
-
CLINICAL_TRIALS trial_result · 2010-10-07Clinical Trial Update: Assess the Oral Bioavailability of New ABT-263 Formulations [Phase 1]
Phase 1 pharmacokinetic study assessing oral bioavailability of new ABT-263 formulations.
-
CLINICAL_TRIALS trial_result · 2010-10-06Clinical Trial Update: AMD3100 (Plerixafor) Added to a Mobilizing Regimen of Granulocyte-colony Stimulating Factor (G-CSF) to Increase the Number of Peripheral Blood Stem Cells (PBSCs) in Patients With Hodgkin's Disease [Phase 2]
Phase 2 study evaluating the addition of plerixafor (AMD3100) to a G-CSF mobilization regimen to increase peripheral blood stem cells in pat…